Cargando…
Tranilast for advanced heart failure in patients with muscular dystrophy: a single-arm, open-label, multicenter study
BACKGROUND: The transient receptor potential cation channel subfamily V member 2 (TRPV2) is a stretch-sensitive calcium channel. TRPV2 overexpression in the sarcolemma of skeletal and cardiac myocytes causes calcium influx into the cytoplasm, which triggers myocyte degeneration. In animal models of...
Autores principales: | Matsumura, Tsuyoshi, Hashimoto, Hiroya, Sekimizu, Masahiro, Saito, Akiko M., Motoyoshi, Yasufumi, Nakamura, Akinori, Kuru, Satoshi, Fukudome, Takayasu, Segawa, Kazuhiko, Takahashi, Toshiaki, Tamura, Takuhisa, Komori, Tetsuo, Watanabe, Chigusa, Asakura, Masanori, Kimura, Koichi, Iwata, Yuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109199/ https://www.ncbi.nlm.nih.gov/pubmed/35578298 http://dx.doi.org/10.1186/s13023-022-02352-3 |
Ejemplares similares
-
A Pilot Study of Tranilast for Cardiomyopathy of Muscular Dystrophy
por: Matsumura, Tsuyoshi, et al.
Publicado: (2017) -
Reply to “The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations”
por: Matsumura, Tsuyoshi, et al.
Publicado: (2018) -
Impact of the TRPV2 Inhibitor on Advanced Heart Failure in Patients with Muscular Dystrophy: Exploratory Study of Biomarkers Related to the Efficacy of Tranilast
por: Takahashi, Chisato, et al.
Publicado: (2023) -
A web-based questionnaire survey on the influence of coronavirus disease-19 on the care of patients with muscular dystrophy
por: Matsumura, Tsuyoshi, et al.
Publicado: (2021) -
The Effects of Tranilast on Cardiomyopathy in Becker Muscular Dystrophy Requires Profound Cardiac and Neurologic Evaluations
por: Stöllberger, Claudia, et al.
Publicado: (2018)